Related Experiment Video
Updated: Aug 11, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Evaluation of hypertension in systemic sclerosis and systemic lupus erythematosus overlap
Erin Chew1, April Barnado1, Talat Alp Ikizler2,3
1Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Insights
Diagnosing and managing hypertension in patients with overlapping systemic sclerosis and systemic lupus erythematosus requires careful consideration of treatment differences. Advanced imaging techniques can help assess long-term vasculopathy progression in these complex cases.
Area of Science:
- Rheumatology
- Nephrology
- Cardiology
Background:
- Hypertension in patients with overlapping systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) presents unique clinical challenges.
- Treatment strategies for non-renal crisis hypertension differ significantly between SSc and SLE.
- Early and accurate diagnosis is crucial for effective management.
Purpose of the Study:
- To discuss the diagnostic approach for patients with SSc and SLE overlap who present with hypertension.
- To highlight the importance of differentiating management strategies based on underlying autoimmune serologies.
- To explore the role of advanced imaging in assessing long-term vasculopathy.
Main Methods:
- Review of current literature on hypertension management in SSc and SLE overlap.
- Discussion of diagnostic criteria and urgent laboratory studies.
- Evaluation of imaging modalities for assessing vasculopathy.
Main Results:
- Urgent laboratory studies and, in symptomatic cases, imaging are indicated for SSc-SLE overlap patients with hypertension.
- Non-contrast imaging advances offer potential biomarkers for progressive vasculopathy.
- Distinct treatment choices exist for non-renal crisis hypertension in SSc versus SLE.
Conclusions:
- A tailored diagnostic and management approach is essential for hypertensive patients with SSc-SLE overlap.
- Long-term monitoring using advanced imaging can improve assessment of vasculopathy.
- Understanding the nuances between SSc and SLE is critical for optimal patient outcomes.
Abstract:
Patients with systemic sclerosis and systemic lupus erythematosus serologies present a unique challenge to the clinician when hypertension is detected in the outpatient setting. Treatment choices for non-renal crisis hypertension are different for systemic sclerosis versus systemic lupus erythematosus. Urgent laboratory studies and, in the presence of certain symptoms, imaging assessment are indicated in systemic sclerosis and systemic lupus erythematosus overlap patients with systemic hypertension. Long-term assessment of systemic hypertension may be enhanced by advances in non-contrast imaging that serve as valuable biomarkers for progressive vasculopathy. In this review, the diagnostic approach to systemic sclerosis and systemic lupus erythematosus overlap patients presenting with hypertension is discussed.
More Related Videos
07:25Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.